Chikungunya is a disease transmitted to humans by mosquitoes in Africa, Asia, and the Americas, with sporadic cases reported in other locations. Its symptoms often resemble those of dengue and ...

Confirming a Cell Structure’s Role ... The study is titled “Chikungunya virus cell-to-cell transmission is mediated by intercellular extensions in vitro and in vivo.” ...

The FDA on Thursday announced approval of Ixchiq, the first chikungunya vaccine, for anyone 18 and older who has a risk of being exposed to the mosquito-borne virus.

Like other alphaviruses, CHIKV contains an RNA genome of approximately 11.8 kB that is single stranded and messenger ('positive strand') sense (Figure 1). The genomic RNA is capped and ...

The U.S. Food and Drug Administration on Thursday approved the first vaccine against chikungunya virus, a disease that is primarily transmitted to people through infected mosquito bites. The ...

Most people don't die from the virus. In fact, you'll probably recover in a few weeks. Acute symptoms usually end after 7 to 10 days. There can be long-term effects from getting the chikungunya virus.